Director Out As Sigma Xi Ponders Role

BOSTON—The executive director of Sigma Xi, one of the nation's oldest and most prestigious scientific societies, has been forced out in a bitter dispute over the proper role of the organization. C. Ian Jackson, hired in 1981 as an outsider with a new vision for the 101-year-old honorary society, was asked to leave June 19 by the organization's board of directors. The board was scheduled to meet last weekend to discuss plans for choosing his successor. "I am not leaving voluntarily," Jackso

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

C. Ian Jackson, hired in 1981 as an outsider with a new vision for the 101-year-old honorary society, was asked to leave June 19 by the organization's board of directors. The board was scheduled to meet last weekend to discuss plans for choosing his successor.

"I am not leaving voluntarily," Jackson asserted in an interview from his home in New Haven, Conn., the headquarters of the society. "I would have liked to stay on and complete some of the changes that have begun, but I don't want to make more controversy than already exists."

Although his departure appears to be the result of a major ideological battle over the direction the society should take, insiders also portray it as the culmination of problems caused by Jackson's management style.

Klaus Timmerhaus, a chemical engineer at the University of Colorado at Boulder and incoming president of the society, called the current situation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Seth Shulman

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide